Found: 109
Select item for more details and to access through your institution.
Erratum: Nature Biotechnology's academic spinouts of 2016.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 8, p. 797, doi. 10.1038/nbt0817-797b
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts of 2016.
- Published in:
- Nature Biotechnology, 2017, v. 35, n. 4, p. 322, doi. 10.1038/nbt.3847
- By:
- Publication type:
- Article
Erratum: Nature Biotechnology's academic spinouts of 2015.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 8, p. 888, doi. 10.1038/nbt0816-888c
- By:
- Publication type:
- Article
White House unveils National Microbiome Initiative.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 6, p. 580, doi. 10.1038/nbt0616-580a
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts of 2015.
- Published in:
- Nature Biotechnology, 2016, v. 34, n. 5, p. 484, doi. 10.1038/nbt.3564
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts of 2014.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 3, p. 247, doi. 10.1038/nbt.3163
- By:
- Publication type:
- Article
Markets, venture investors and big pharma interest in RNAi soars.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 3, p. 203, doi. 10.1038/nbt0314-203
- By:
- Publication type:
- Article
Nature Biotechnology's academic spinouts of 2013.
- Published in:
- Nature Biotechnology, 2014, v. 32, n. 3, p. 229, doi. 10.1038/nbt.2846
- By:
- Publication type:
- Article
GSK plows ahead with EMA malaria vaccine submission.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 12, p. 1066, doi. 10.1038/nbt1213-1066a
- By:
- Publication type:
- Article
First-in-class anemia drug takes aim at Amgen's dominion.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 11, p. 948, doi. 10.1038/nbt1113-948b
- By:
- Publication type:
- Article
Dengue clinches Takeda deal.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 8, p. 667, doi. 10.1038/nbt0813-667
- By:
- Publication type:
- Article
First microRNA mimic enters clinic.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 7, p. 577, doi. 10.1038/nbt0713-577
- By:
- Publication type:
- Article
SGLT2 inhibitors enter crowded diabetes space.
- Published in:
- Nature Biotechnology, 2013, v. 31, n. 6, p. 469, doi. 10.1038/nbt0613-469
- By:
- Publication type:
- Article
Companies in footrace to deliver RNAi.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 12, p. 1154, doi. 10.1038/nbt1212-1154
- By:
- Publication type:
- Article
Regulatory fog lifts on obesity drugs.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 9, p. 810, doi. 10.1038/nbt0912-810b
- By:
- Publication type:
- Article
Clinical trial data: to disclose or not to disclose?
- Published in:
- Nature Biotechnology, 2006, v. 24, n. 9, p. 1058, doi. 10.1038/nbt0906-1058
- By:
- Publication type:
- Article
Getting the right mix.
- Published in:
- 2006
- By:
- Publication type:
- Report
News In Brief.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 2, p. 161, doi. 10.1038/nbt0205-161
- By:
- Publication type:
- Article
News In Brief.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 11, p. 1339, doi. 10.1038/nbt1104-1339
- By:
- Publication type:
- Article
Coming soon: a global grid for cancer research.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 9, p. 1071, doi. 10.1038/nbt0904-1071
- By:
- Publication type:
- Article
McClellan moves on, sets sights on drug reimbursement.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 4, p. 366, doi. 10.1038/nbt0404-366
- By:
- Publication type:
- Article
News In Brief.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 3, p. 259, doi. 10.1038/nbt0304-259
- By:
- Publication type:
- Article
Erratum: Cancer trials get set for biomarkers.
- Published in:
- 2004
- By:
- Publication type:
- Correction notice
Erratum: 3Q financial roundup.
- Published in:
- 2004
- By:
- Publication type:
- Correction notice
Cancer trials get set for biomarkers.
- Published in:
- Nature Biotechnology, 2004, v. 22, n. 1, p. 6, doi. 10.1038/nbt0104-6
- By:
- Publication type:
- Article
Companies jostle for access to public markets.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 12, p. 1413, doi. 10.1038/nbt1203-1413
- By:
- Publication type:
- Article
NEWS IN BRIEF.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 11, p. 1261, doi. 10.1038/nbt1103-1261
- By:
- Publication type:
- Article
New rules for US drug reimbursement.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 10, p. 1119, doi. 10.1038/nbt878
- By:
- Publication type:
- Article
Increasing number of companies found ineligible for SBIR funding.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 10, p. 1121, doi. 10.1038/nbt883
- By:
- Publication type:
- Article
Roche and Igen in shotgun wedding.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 9, p. 958, doi. 10.1038/nbt0903-958a
- By:
- Publication type:
- Article
News In Brief.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 9, p. 961, doi. 10.1038/nbt0903-961
- By:
- Publication type:
- Article
Industry reneges on postmarketing trial commitments.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 7, p. 718, doi. 10.1038/nbt0703-718
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 5, p. 473, doi. 10.1038/nbt0503-473
- By:
- Publication type:
- Article
Industry ponders reimbursement crisis.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 4, p. 347, doi. 10.1038/nbt0403-347
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 1, p. 9, doi. 10.1038/nbt0103-9
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 1, p. 39, doi. 10.1038/nbt0103-39
- By:
- Publication type:
- Article
The Nature Biotechnology 2003 New Year Quiz.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 1, p. 106, doi. 10.1038/nbt0103-106
- By:
- Publication type:
- Article
Tissue engineering firms go under.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 12, p. 1178, doi. 10.1038/nbt1202-1178
- By:
- Publication type:
- Article
FDA restructures new product review centers.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 10, p. 960, doi. 10.1038/nbt1002-960a
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 10, p. 965, doi. 10.1038/nbt1002-965
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 8, p. 763, doi. 10.1038/nbt0802-763
- By:
- Publication type:
- Article
New SEC regulations could hinder biotech investment.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 7, p. 639, doi. 10.1038/nbt0702-639b
- By:
- Publication type:
- Article
Harvester of sorrow.
- Published in:
- 2002
- By:
- Publication type:
- Book Review
Cellzome.
- Published in:
- Nature Biotechnology, 2002, v. 20, p. BE15, doi. 10.1038/nbt0602supp-BE15
- By:
- Publication type:
- Article
Caprion Pharmaceuticals.
- Published in:
- Nature Biotechnology, 2002, v. 20, p. BE20, doi. 10.1038/nbt0602supp-BE20b
- By:
- Publication type:
- Article
Pieris ProteoLab.
- Published in:
- Nature Biotechnology, 2002, v. 20, p. BE20, doi. 10.1038/nbt0602supp-BE20a
- By:
- Publication type:
- Article
Organic farmers sue GMO producers.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 3, p. 210, doi. 10.1038/nbt0302-210
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 3, p. 211, doi. 10.1038/nbt0302-211
- By:
- Publication type:
- Article
Shift anticipated in DNA microarray market.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 1, p. 8, doi. 10.1038/nbt0102-8
- By:
- Publication type:
- Article
In Brief.
- Published in:
- Nature Biotechnology, 2002, v. 20, n. 1, p. 9, doi. 10.1038/nbt0102-9
- By:
- Publication type:
- Article